Phathom Pharmaceuticals Inc (PHAT)
7.61
+0.16
(+2.15%)
USD |
NASDAQ |
Dec 23, 16:00
7.61
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Cash from Investing (Quarterly): -0.044M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -3.845B |
| Galectin Therapeutics Inc | -- |
| AbbVie Inc | -8.256B |
| Poseida Therapeutics Inc | 27.65M |
| Janux Therapeutics Inc | 12.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -63.57M |
| Cash from Financing (Quarterly) | 122.06M |
| Free Cash Flow | -247.72M |
| Free Cash Flow Per Share (Quarterly) | -0.9844 |
| Free Cash Flow to Equity (Quarterly) | -64.92M |
| Free Cash Flow Yield | -54.50% |